geneticsandsociety.org

geneticsandsociety.org is the website of the Center for Genetics and Society (CGS). Its content is primarily commentary, policy analysis, book reviews, and aggregated news about human genetics, biotechnology, and their social and ethical implications. Writers include CGS staff, guest contributors, and journalists whose work is republished or cited from other outlets. If you want to follow debates around gene editing, eugenics, and genomic research rather than read original peer-reviewed studies, this site is aimed at you.

Main content sections

The site organizes material into several recurring sections and formats:

• Biopolitical Times — CGS's own commentary and analysis stream, where staff and contributors publish pieces on current developments.
• Aggregated News — articles originally published elsewhere, reposted or summarized with attribution.
• Series — themed, multi-part collections. The page evidence shows "Legacies of Eugenics," described as a series of essays by leading thinkers exploring the history of eugenics and how it shapes the present, organized by Osagie K. Obasogie. The featured item was labeled the 16th installment.
• Book reviews — e.g., a review by Pete Shanks of What We Inherit by Sam Trejo and Daphne O. Martschenko and Original Sin by Kathryn Paige Harden.
• Topic tags — visible categories include Human Genetic Modification, Genomics, U.S. Federal, and U.S. States.

Who writes the content

Writers fall into a few recognizable groups:

So a byline on the site does not automatically mean the author works for CGS. Some pieces are republished from outlets such as the Los Angeles Review of Books, Mother Jones, Nature, and GMWatch, and some cite CGS staff as sources rather than being written by them.

What the content actually covers

Recurring subjects visible on the homepage include:

• Human genetic modification, including embryo gene editing and the prospect of gene-edited babies.
• Eugenics and its legacies, treated as a historical and ongoing social issue.
• Genomics and society, including reviews of trade books on genomic research.
• Policy and institutions, such as reporting on Palantir's involvement in an NIH health initiative.
• Gene therapy and epigenetic therapies, including critical coverage of hype and of a trial that ended in a child's death.

How to use the site

• To follow CGS's own positions, read Biopolitical Times.
• To scan what other outlets are reporting, use Aggregated News.
• To go deep on one theme, follow a series such as Legacies of Eugenics.
• To browse by subject, use the topic tags (Human Genetic Modification, Genomics, U.S. Federal, U.S. States).

The site also offers a Subscribe link at geneticsandsociety.org/subscribe. The available page evidence does not state whether subscribing involves a fee or a login requirement, so check the page itself before assuming it is free.

One practical caveat: because aggregated and republished items appear alongside original CGS writing, check the byline and the source line before attributing a claim to CGS itself.

geneticsandsociety.org is the website of the Center for Genetics and Society, an organization that publishes news, commentary, and policy analysis on how human genetics and biotechnology affect society. It is useful if you want critical, ethics- and policy-oriented coverage of topics such as eugenics history, human genetic modification, gene editing, and genomics research — rather than technical or clinical genetics content. The site also offers a subscription option for updates.

What the site covers

CGS functions as a publisher and aggregator rather than a database or research tool. Its content falls into a few recurring categories:

• Human genetic modification — including gene-edited embryos and heritable genome editing
• Eugenics and its legacies — a running essay series on the history of eugenics and how it shapes present-day debates
• Genomics and society — commentary on large-scale genomics and health initiatives
• Biopolitical Times — the organization's own blog/commentary stream
• Aggregated news — articles from other outlets, sometimes citing CGS staff

How content is organized

The homepage surfaces a "Featured" section with recent items. Each entry typically shows a title, author, publication or series name, and a date. Examples visible on the site include:

This mix shows the site's editorial stance: it tracks developments in genetics while foregrounding ethical, social, and regulatory questions, and it republishes or excerpts reporting from partner and external outlets.

Who it's for

The site is most relevant if you are:

• Researching the social and ethical dimensions of genetics, not lab methods
• Looking for critical perspectives on gene editing, gene therapy, or genomics policy
• Following the history of eugenics and its connections to current politics
• Seeking commentary you can cite or follow through a subscription

It is less suited for people wanting clinical guidance, raw datasets, or technical protocols.

Getting updates

The site provides a subscription page at geneticsandsociety.org/subscribe for receiving updates. The available material does not state terms, frequency, or cost, so check the page directly before subscribing.

A practical way to use the site

If you're tracking a specific issue — for example, embryo gene editing — start from the topic label attached to each item (such as "Human Genetic Modification") and read the Biopolitical Times entries alongside the aggregated news pieces. The pairing gives you both CGS's analysis and the underlying reporting it responds to, which is the site's main value: a curated, advocacy-informed view of where genetics and society intersect.

The Center for Genetics and Society (CGS) provides a subscription option through its website at geneticsandsociety.org/subscribe. If you want to receive CGS's news and article updates, that page is the entry point. The site lists "Subscribe" as a pricing-related link, but the available page evidence does not specify whether subscription is free, paid, or requires account registration — so check the page itself for current terms before signing up.

What you get by subscribing

CGS publishes commentary and aggregated news on human genetics and its social implications. Based on the site's featured content, subscribers can expect material such as:

• Biopolitical Times posts — CGS's own blog, e.g., Pete Shanks' reviews of What We Inherit and Original Sin (08.28.2026), and Katie Hasson's analysis of reporting on gene-edited embryos (07.11.2026).
• Aggregated News — external reporting republished or cited by CGS, e.g., Terence Keel's essay in the Legacies of Eugenics series (09.06.2026) and a Mother Jones piece on Palantir and an NIH health initiative (07.07.2026).
• Themed series — recurring collections such as Legacies of Eugenics, organized by Osagie K. Obasogie.

Recurring topic areas visible on the homepage include Human Genetic Modification, Genomics, U.S. Federal policy, and U.S. States.

How to find the subscription page

1. Go to geneticsandsociety.org.
2. Look in the main navigation or the site footer for a "Subscribe" link.
3. Alternatively, go directly to geneticsandsociety.org/subscribe.

Expected result: you land on a page where you can enter your details to receive updates. The exact form fields and any confirmation steps are not described in the available site data, so treat the page itself as the source of truth.

Common snags

• No stated price or login requirement. The site shows a "Subscribe" link but no payment platform or pricing detail in the available evidence. Don't assume it's free or that no account is needed — verify on the page.
• Subscribe vs. follow. If you only want occasional updates without email, checking the homepage's "Featured" section works as a manual alternative, since new items appear there with dates and authors.
• Content language. The site is in English, so subscription emails and articles will be in English.

If you'd rather not subscribe

You can still track CGS output by revisiting the homepage, where featured articles are listed with author, publication, and date — for example, the 09.21.2026 Nature item on epigenetic editing and hepatitis B, or the 08.25.2026 guest piece on a gene therapy trial. This gives you the same headline-level view without any signup.

The Center for Genetics and Society (CGS), at geneticsandsociety.org, is a nonprofit affairs and advocacy site that focuses on the social, ethical, and political implications of human genetic and reproductive technologies. Its coverage clusters around four recurring themes: the legacies of eugenics, human genetic modification (especially embryo editing), the societal impact of genomic research, and U.S. federal policy and biopolitics. If you want critical, policy-oriented commentary on where human genetics is heading—rather than technical lab protocols—this is the kind of source to check.

Eugenics and Its Legacies

CGS treats the history of eugenics as a live issue, not a closed chapter. A recurring example is its "Legacies of Eugenics" series, which the site describes as featuring essays by leading thinkers "devoted to exploring the history of eugenics and the ways it shapes our present." One installment shown on the homepage is "Eugenics and the Nihilism of Law-and-Order Politics" by Terence Keel, published in the Los Angeles Review of Books and aggregated by CGS.

This thread is useful if your question is about how past eugenic ideas connect to current debates over policing, immigration, or reproductive policy.

Human Genetic Modification and Embryo Editing

This is one of the site's most active topics. A representative piece is "Taking a closer look at recent reporting on gene-edited embryos" by Katie Hasson, which examines how media coverage can make gene-edited babies seem imminent. CGS also covers gene therapy controversies, such as an article on a gene therapy trial that "ends in a child's death," described by its authors as characterized by "hype and hubris."

If you are trying to understand the gap between headlines about embryo editing and the actual state of the science, this category is directly relevant.

Social and Ethical Impact of Genomic Research

CGS regularly reviews books that wrestle with what genomics means for society. A featured example reviews What We Inherit by Sam Trejo and Daphne O. Martschenko and Original Sin by Kathryn Paige Harden, noting both attempt to show where human genomics research stands and why it matters. The site's framing: "the influence of genomic research on our societies is already large and seems likely to change them."

This section suits readers interested in behavioral genetics, heritability debates, and how genomic findings get translated into social claims.

U.S. Federal Policy and Biopolitics

CGS tracks the political and institutional side of genetics. One example covers Palantir's involvement in an NIH health initiative, aggregating reporting from Mother Jones that cites CGS's Katie Hasson. Another covers "epigenetic" editing research, drawn from Nature.

These items help if your interest is in how federal programs, contractors, and funding shape genetic research priorities.

How the Content Is Organized

The site also offers a Subscribe link, which suggests you can follow new posts; the available material does not specify whether subscription involves a cost or a login requirement, so check the page directly before assuming either.

When This Site Is the Right Source

Use CGS when you need a critical, ethics-and-policy lens on human genetic technologies—eugenics history, embryo editing, genomic research's social reach, and U.S. biopolitics. It is less suited to readers seeking neutral technical summaries or clinical guidance, since its content is explicitly oriented toward examining social consequences and raising concerns.

The Center for Genetics and Society (CGS), at geneticsandsociety.org, approaches human genetics primarily as a social, ethical, and policy question rather than a purely scientific or medical one. Its perspective is critical and precautionary: it treats technologies such as gene editing, heritable genetic modification, and commercial genomics as developments whose consequences for equality, justice, and democracy need to be examined before they are celebrated. If you are looking for a source that reports on genetics while foregrounding eugenics history, regulatory gaps, and civil society concerns, this site is written from that standpoint. If you want technical protocols or clinical guidance, it is not that kind of resource.

The core stance: genetics as a social question

CGS frames its work around the idea that genetic and reproductive technologies do not arrive in a neutral world. Its coverage repeatedly connects new tools to older histories of eugenics, race science, and state power. The site's featured essay, "Eugenics and the Nihilism of Law-and-Order Politics" by Terence Keel (Los Ángeles Review of Books, 09.06.2026), is described as the 16th installment in the Legacies of Eugenics series, which "features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present." That framing is the clearest statement of the site's angle: past eugenics is treated as continuous with present-day debates, not as a closed historical chapter.

What that looks like in practice

The perspective shows up in how stories are selected and headlined.

• Skepticism toward hype. A piece on a gene therapy trial is titled "Gene therapy trial characterised by hype and hubris ends in a child's death" (Claire Robinson and Jonathan Matthews, guest contributors, 08.25.2026). The emphasis is on the gap between promotional claims and outcomes.
• Caution on embryo editing. Katie Hasson's "Taking a closer look at recent reporting on gene-edited embryos" (07.11.2026) examines how media coverage "might seem to suggest that gene-edited babies are close to becoming" a reality — and interrogates that impression rather than repeating it.
• Attention to institutional and commercial entanglements. "Palantir Has a Hand in NIH's Most Ambitious Health Initiative" (Julia Métraux, Mother Jones, 07.07.2026, citing CGS's Katie Hasson) looks at who holds data and power in large public health programs.
• Engagement with the genomics literature. Pete Shanks reviews What We Inherit by Sam Trejo and Daphne O. Martschenko and Original Sin by Kathryn Paige Harden (08.28.2026), noting that "the influence of genomic research on our societies is already large and seems likely to change them."

Across these, the recurring move is to ask who benefits, who is harmed, and what oversight exists — not simply what is technically possible.

How the site organizes its material

Content is grouped by topic and format, which makes the editorial perspective easy to trace:

The presence of tags like "U.S. Federal" and "U.S. States" alongside "Human Genetic Modification" confirms that governance and law are treated as central, not incidental.

What this means for a reader

Use CGS if you want:

• Critical analysis of gene editing, heritable modification, and reproductive technology
• Historical context connecting eugenics to contemporary genetics policy
• Pointers to external reporting and books, filtered through a social-justice lens

Do not rely on it as a neutral wire service or a source of clinical or laboratory guidance. Its value is in the questions it raises and the histories it keeps in view.

Staying current

The site offers a subscription path at geneticsandsociety.org/subscribe for updates. The page evidence shows a "Subscribe" link and the keyword "subscribe," but does not specify a price or whether an account is required — so treat cost and login requirements as unconfirmed and check the page directly before assuming either way.